Search for new products by date added, alphabetically, or by pharmacological action.
New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules and peptides being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can. New products can be identified throughout the Tocris website by the New symbol.
If you can't find what you are looking for we welcome new product suggestions. If you would like to be kept informed about new products by email, please sign up for our monthly e-alert service.
| Cat No | Product Name / Activity | Date Added |
|---|---|---|
| 6578 | GT 949 | Jul 2018 |
| Selective EAAT2 PAM | ||
| 6544 | CID 1375606 | Jul 2018 |
| GPR27 agonist | ||
| 6436 | CY 09 | Jul 2018 |
| NLRP3 inhibitor; active in vivo | ||
| 6273 | CRT 0105950 | Jul 2018 |
| Potent LIMK1/2 inhibitor | ||
| 5767 | SR 3029 | Jul 2018 |
| Potent and selelctive CK1δ and CK1ε inhibitor | ||
| 6324 | Autophinib | Jul 2018 |
| Potent VPS34 inhibitor | ||
| 6281 | SLM 6031434 hydrochloride | Jul 2018 |
| Sphingosine kinase 2 (Sphk2) inhibitor | ||
| 6564 | SGC GAK 1 | Jul 2018 |
| High affinity cyclin G associated kinase (GAK) inhibitor | ||
| 6558 | CP 43 | Jul 2018 |
| Potent TAOK inhibitor | ||
| 6320 | ESI 05 | Jul 2018 |
| EPAC2 inhibitor | ||
| 6179 | UK 59811 hydrochloride | Jul 2018 |
| CaVAb blocker | ||
| 6239 | SAK 3 | Jul 2018 |
| Potent CaV3.1/3.3 activator; orally bioavailable | ||
| 6040 | BRD 9757 | Jul 2018 |
| Potent and selective HDAC6 inhibitor | ||
| 6554 | (+)-Abscisic Acid | Jun 2018 |
| Endogenous LANCL2 agonist | ||
| 6505 | Avasimibe | Jun 2018 |
| ACAT inhibitor | ||
| 6448 | ML 351 | Jun 2018 |
| Selective 12/15 LOX inhibitor; active in vivo | ||
| 6144 | CX08005 | Jun 2018 |
| Competitive PTP1B inhibitor | ||
| 6079 | TC KHNS 11 | Jun 2018 |
| Potent and selective PI 3-kinase δ inhibitor; orally bioavailable | ||
| 6037 | LM22B 10 | Jun 2018 |
| TrkB and TrkC agonist; brain penetrant | ||
| 5828 | Ambrisentan | Jun 2018 |
| Selective ETA antagonist | ||
| 6406 | Hydroxystilbamidine bis(methanesulfonate) | Jun 2018 |
| Fluorescent cationic dye; neuronal tracer | ||
| 6572 | Biotin-LC-NAD+ | Jun 2018 |
| Biotinylated analog of beta -NAD+. Commonly used reagent in LSD1 and PARP1 assays | ||
| 6549 | cAC 253 | Jun 2018 |
| Amylin (AMY3) antagonist; brain penetrant | ||
| 6571 | Biotin-11-dUTP | Jun 2018 |
| Biotin-labeled dUTP | ||
| 6296 | Janelia Fluor® 525, SE | Jun 2018 |
| Cell permeable yellow fluorescent dye; supplied as NHS ester | ||
| 6552 | PAMP-20 (human) | Jun 2018 |
| MRGPRX2 agonist | ||
| 6551 | PAMP-12 (human, porcine) | Jun 2018 |
| Potent MRGPRX2 agonist | ||
| 6113 | Liproxstatin-1 hydrochloride | Jun 2018 |
| Potent ferroptosis inhibitor | ||
| 6550 | AC 253 | May 2018 |
| Amylin receptor antagonist | ||
| 6548 | N-(3-Oxododecanoyl)-L-homoserine lactone | May 2018 |
| Bacterial quorum sensing autoinducer; immunomodulator | ||
| 6017 | THPN | May 2018 |
| Nur77 agonist; induces autophagy in melanoma cell lines | ||
| 6244 | OG-L002 | May 2018 |
| Potent LSD1 inhibitor | ||
| 6484 | Terbinafine hydrochloride | May 2018 |
| Selective TASK3 activator; also inhibits fungal squalene epoxidase | ||
| 6507 | Saxagliptin hydrochloride | May 2018 |
| High affinity DPP-IV inhibitor; active in vivo | ||
| 3036 | Loxiglumide | May 2018 |
| CCK1 antagonist; active in vivo | ||
| 6383 | SR 16832 | May 2018 |
| Dual site PPARγ inhibitor | ||
| 6223 | XY 018 | May 2018 |
| RORγ antagonist; inhibits AR expression | ||
| 6387 | A 485 | May 2018 |
| Potent and selective p300/CBP inhibitor; orally bioavailable | ||
| 6440 | PIK 93 | May 2018 |
| Potent PI 3-Kγ, PI 3-Kα and PI 4-KIIIβ inhibitor | ||
| 6166 | AMG 18 hydrochloride | May 2018 |
| Potent and selective IRE1α inhibitor | ||
| 6139 | NS 6740 | May 2018 |
| High affinity α7 nAChR partial agonist; anti-inflammatory | ||
| 6494 | Galangin | Apr 2018 |
| TRPC5 inhibitor; also induces autophagy | ||
| 6469 | Thalidomide - linker 3 | Apr 2018 |
| Functionalized cereblon ligand for PROTACs; incorporates an E3 ligase ligand plus a short alkyl linker | ||
| 6467 | Thalidomide - linker 1 | Apr 2018 |
| Functionalized cereblon ligand for PROTACs; incorporates an E3 ligase ligand plus a PEG linker | ||
| 6465 | VH 032 - linker 3 | Apr 2018 |
| Functionalized VHL ligand for PROTACs; incorporates an E3 ligase ligand plus a short alkyl linker | ||
| 6438 | BRD 6989 | Apr 2018 |
| Cdk8 inhibitor; enhances IL-10 production | ||
| 6468 | Thalidomide - linker 2 | Apr 2018 |
| Functionalized cereblon ligand for PROTACs; incorporates an E3 ligase ligand plus a PEG linker | ||
| 6463 | VH 032 - linker 1 | Apr 2018 |
| Functionalized VHL ligand for PROTACs; incorporates an E3 ligase ligand plus a PEG linker | ||
| 6455 | Tocriscreen Plus Micro | Apr 2018 |
| A library of 1280 biologically active compounds (15 μL 10 mM DMSO solutions) | ||
| 6464 | VH 032 - linker 2 | Apr 2018 |
| Functionalized VHL ligand for PROTACs; incorporates an E3 ligase ligand plus a PEG linker | ||
| 6417 | CMP 98 | Apr 2018 |
| Negative Control for CM 11 | ||
| 6416 | CM 11 | Apr 2018 |
| Homo-PROTAC for self-degradation of pVHL30 | ||
| 6515 | (D)-PPA 1 | Apr 2018 |
| PD-1/PD-L1 interaction inhibitor | ||
| 6409 | A 1210477 | Apr 2018 |
| Selective, high affinity Mcl-1 inhibitor; proapoptotic | ||
| 3649 | CP 122721 hydrochloride | Apr 2018 |
| High affinity NK1 receptor antagonist | ||
| 4647 | GR 203040 | Apr 2018 |
| Potent, selective NK1 receptor antagonist | ||
| 6435 | ML 323 | Apr 2018 |
| Potent and selective USP1-UAF1 allosteric inhibitor | ||
| 6392 | B02 | Apr 2018 |
| RAD51 recombinase inhibitor | ||
| 5730 | A 127722 | Mar 2018 |
| Highly potent, selective ETA antagonist; orally bioavailable | ||
| 6410 | Tipifarnib | Mar 2018 |
| Potent farnesyltransferase inhibitor; orally bioavailable | ||
| 6462 | VH 032, amine hydrochloride | Mar 2018 |
| Functionalized VHL ligand for PROTACs | ||
| 6241 | Biotinyl Tyramide | Mar 2018 |
| Reagent widely used for signal amplification in IHC and ISH | ||
| 6344 | OUL 35 | Mar 2018 |
| Selective PARP-10 inhibitor | ||
| 6466 | TC E3 5031 | Mar 2018 |
| Functionalized cereblon ligand for PROTACs | ||
| 6411 | tBPC | Mar 2018 |
| Positive allosteric modulator of NPY Y4 receptor | ||
| 6300 | Azido-Thalidomide | Mar 2018 |
| Click-functionalized thalidomide | ||
| 6450 | Cortagine | Mar 2018 |
| Potent and selective CRF1 agonist | ||
| 6133 | NVS PAK1 C | Mar 2018 |
| Negative control of NVS PAK1 1 (Cat. No. 6132) | ||
| 6249 | Givinostat hydrochloride | Feb 2018 |
| Histone deacetylase inhibitor | ||
| 6341 | INF 39 | Feb 2018 |
| Irreversible NLRP3 inhibitor | ||
| 6431 | Phentolamine Mesylate | Feb 2018 |
| Adrenergic α receptor antagonist; antihypertensive | ||
| 6356 | AT 1 | Feb 2018 |
| (+)-JQ1 based PROTAC with selectivity for BRD4 | ||
| 6242 | AG 205 | Feb 2018 |
| Progesterone receptor membrane component 1 (Pgrmc1) ligand | ||
| 5815 | SCH 336 | Feb 2018 |
| Highly potent and selective CB2 inverse agonist | ||
| 6382 | MAIT 203 | Jan 2018 |
| APC-Asef interaction inhibitor | ||
| 6118 | 1S,3R-RSL3 | Jan 2018 |
| Induces ferroptosis; inhibits glutathione peroxidase 4 (GPX4) | ||
| 6420 | Janelia Fluor® 669, SE | Jan 2018 |
| Cell permeable far red fluorescent dye; supplied as NHS ester | ||
| 6418 | Janelia Fluor® 585, SE | Jan 2018 |
| Cell permeable orange fluorescent dye; supplied as NHS ester | ||
| 6419 | Janelia Fluor® 635, SE | Jan 2018 |
| Cell permeable red fluorescent dye; supplied as NHS ester | ||
| 5920 | LG 100268 | Jan 2018 |
| Potent and selective RXR agonist; also activates RXR/PPARγ heterodimers |